European registry for anomalous aortic origin of coronary arteries
Part of Genetic & congenital, Heart & circulation clinical trials.
This is a European registry for people with an anomalous origin of a coronary artery from the aorta (AAOCA). It will track how the condition is treated—whether with surgery or monitoring—to learn what works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with anomalous aortic origin of a coronary artery (AAOCA).
- Your anomaly is not just a high take-off (origin more than 5mm above normal).
- Your anomaly is not a circumflex artery coming from the right coronary artery.
- Your anomaly is not an origin that is off but the artery runs normally.
- You do not have other major heart birth defects like Tetralogy of Fallot or transposition of the great arteries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, faster way to diagnose an uncommon heart condition where one of the main arteries (the coronary artery) starts from the wrong place on the aorta. The goal is to help doctors find and treat it sooner.
This study collects and shares anonymous information about adults being considered for a heart transplant because of a congenital (from birth) heart problem or an inherited heart muscle condition. The goal is to better understand these patients and support research that may improve care.
This study collects information from people diagnosed with aortic coarctation before or shortly after birth, to better understand the condition and improve care. It may be a fit if you or your child were diagnosed before or within one month of birth.
This study follows adults who are having aortic valve replacement to better understand outcomes across different hospitals in Europe. It may help your care team compare results and improve future treatment planning.
This study follows adults who have a coronary artery anomaly and are getting a medically needed heart test at the study hospital. Researchers collect information from those tests to better understand outcomes and what different findings mean.
This study creates a tool to help patients and families with a rare heart condition called R-AAOCA (right anomalous aortic origin of a coronary artery) make informed decisions about their care. The tool aims to improve understanding and shared decision-making between patients and doctors.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.